Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Current Opinion in Rheumatology
|
June 27, 2012
Pharmacogenomics in pediatric rheumatology
Mara L Becker
Clinical and Translational Science
|
December 2, 2017
Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources
Mara L Becker, Ryan S Funk
Clinical Pharmacology and Therapeutics
|
June 20, 2021
Seeking Similarities Rather Than Differences With Adults to Aid in Therapeutic Advancement for Children
Mara L Becker, Walter K Kraft
Frontiers in Pharmacology
|
December 27, 2021
Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis
Ryan Sol Funk, Mara L Becker
Pharmacogenomics
|
December 3, 2010
Identifying genomic and developmental causes of adverse drug reactions in children
Mara L Becker, J Steven Leeder
Human Genomics and Proteomics : HGP
|
October 29, 2010
Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate
Mara L Becker, J Steven Leeder
Best Practice & Research. Clinical Rheumatology
|
June 30, 2014
Therapeutic advancements in juvenile idiopathic arthritis
Elizabeth A Kessler, Mara L Becker
Current Allergy and Asthma Reports
|
February 9, 2021
Distinguishing Blau Syndrome from Systemic Sarcoidosis
Katherine P Kaufman, Mara L Becker
Discovery Medicine
|
December 17, 2013
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy
Brooke I Polk, Mara L Becker
Current Rheumatology Reports
|
November 24, 2005
Blau syndrome and related genetic disorders causing childhood arthritis
Mara L Becker, Carlos D Rose
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Current Opinion in Rheumatology
|
June 27, 2012
Pharmacogenomics in pediatric rheumatology
Mara L Becker
Clinical and Translational Science
|
December 2, 2017
Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources
Mara L Becker, Ryan S Funk
Clinical Pharmacology and Therapeutics
|
June 20, 2021
Seeking Similarities Rather Than Differences With Adults to Aid in Therapeutic Advancement for Children
Mara L Becker, Walter K Kraft
Frontiers in Pharmacology
|
December 27, 2021
Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis
Ryan Sol Funk, Mara L Becker
Pharmacogenomics
|
December 3, 2010
Identifying genomic and developmental causes of adverse drug reactions in children
Mara L Becker, J Steven Leeder
Human Genomics and Proteomics : HGP
|
October 29, 2010
Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate
Mara L Becker, J Steven Leeder
Best Practice & Research. Clinical Rheumatology
|
June 30, 2014
Therapeutic advancements in juvenile idiopathic arthritis
Elizabeth A Kessler, Mara L Becker
Current Allergy and Asthma Reports
|
February 9, 2021
Distinguishing Blau Syndrome from Systemic Sarcoidosis
Katherine P Kaufman, Mara L Becker
Discovery Medicine
|
December 17, 2013
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy
Brooke I Polk, Mara L Becker
Current Rheumatology Reports
|
November 24, 2005
Blau syndrome and related genetic disorders causing childhood arthritis
Mara L Becker, Carlos D Rose
Page
of 8